{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:05:13Z","timestamp":1791227113906,"version":"4.1.0"},"reference-count":92,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:00:00Z","timestamp":1626048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["646337"],"award-info":[{"award-number":["646337"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hutchinson\u2013Gilford progeria syndrome (HGPS) is an ultra-rare multisystem premature aging disorder that leads to early death (mean age of 14.7 years) due to myocardial infarction or stroke. Most cases have a de novo point mutation at position G608G within exon 11 of the LMNA gene. This mutation leads to the production of a permanently farnesylated truncated prelamin A protein called \u201cprogerin\u201d that is toxic to the cells. Recently, farnesyltransferase inhibitor (FTI) lonafarnib has been approved by the FDA for the treatment of patients with HGPS. While lonafarnib treatment irrefutably ameliorates HGPS disease, it is however not a cure. FTI has been shown to cause several cellular side effects, including genomic instability as well as binucleated and donut-shaped nuclei. We report that, in addition to these cellular stresses, FTI caused an increased frequency of cytosolic DNA fragment formation. These extranuclear DNA fragments colocalized with cGAs and activated the cGAS-STING-STAT1 signaling axis, upregulating the expression of proinflammatory cytokines in FTI-treated human HGPS fibroblasts. Treatment with lonafarnib and baricitinib, a JAK-STAT inhibitor, not only prevented the activation of the cGAS STING-STAT1 pathway, but also improved the overall HGPS cellular homeostasis. These ameliorations included progerin levels, nuclear shape, proteostasis, cellular ATP, proliferation, and the reduction of cellular inflammation and senescence. Thus, we suggest that combining lonafarnib with baricitinib might provide an opportunity to reduce FTI cellular toxicity and ameliorate HGPS symptoms further than lonafarnib alone.<\/jats:p>","DOI":"10.3390\/ijms22147474","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T21:56:37Z","timestamp":1626126997000},"page":"7474","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Baricitinib, a JAK-STAT Inhibitor, Reduces the Cellular Toxicity of the Farnesyltransferase Inhibitor Lonafarnib in Progeria Cells"],"prefix":"10.3390","volume":"22","author":[{"given":"Rouven","family":"Arnold","sequence":"first","affiliation":[{"name":"Epigenetics of Aging, Department of Dermatology and Allergy, TUM School of Medicine, Technical University of Munich (TUM), 85748 Garching, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0623-1403","authenticated-orcid":false,"given":"Elena","family":"Vehns","sequence":"additional","affiliation":[{"name":"Epigenetics of Aging, Department of Dermatology and Allergy, TUM School of Medicine, Technical University of Munich (TUM), 85748 Garching, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Randl","sequence":"additional","affiliation":[{"name":"Epigenetics of Aging, Department of Dermatology and Allergy, TUM School of Medicine, Technical University of Munich (TUM), 85748 Garching, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4067-4977","authenticated-orcid":false,"given":"Karima","family":"Djabali","sequence":"additional","affiliation":[{"name":"Epigenetics of Aging, Department of Dermatology and Allergy, TUM School of Medicine, Technical University of Munich (TUM), 85748 Garching, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,12]]},"reference":[{"key":"ref_1","unstructured":"Gordon, L.B. (2021, July 07). PRF by the Numbers. The Progeria Research Foundation. Available online: https:\/\/www.progeriaresearch.org\/prf-by-the-numbers\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2013.12.028","article-title":"Progeria: A paradigm for translational medicine","volume":"156","author":"Gordon","year":"2014","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1056\/NEJMoa0706898","article-title":"Phenotype and Course of Hutchinson\u2013Gilford Progeria Syndrome","volume":"358","author":"Merideth","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/19491034.2018.1460045","article-title":"An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome","volume":"9","author":"Harhouri","year":"2018","journal-title":"Nucleus"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature01629","article-title":"Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome","volume":"423","author":"Eriksson","year":"2003","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1126\/science.1084125","article-title":"Lamin a truncation in Hutchinson-Gilford progeria","volume":"300","author":"Bernard","year":"2003","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Liu, C., Arnold, R., Henriques, G., and Djabali, K. (2019). Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells. Cells, 8.","DOI":"10.3390\/cells8101276"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1083\/jcb.200904124","article-title":"Role of A-type lamins in signaling, transcription, and chromatin organization","volume":"187","year":"2009","journal-title":"J. Cell Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.advenzreg.2011.11.001","article-title":"Insights into the differences between the A- and B-type nuclear lamins","volume":"52","author":"Adam","year":"2012","journal-title":"Adv. Biol. Regul."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-4933-6-4","article-title":"Molecular ageing in progeroid syndromes: Hutchinson-Gilford progeria syndrome as a model","volume":"6","author":"Coutinho","year":"2009","journal-title":"Immun. Ageing"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.113.008285","article-title":"Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome","volume":"130","author":"Gordon","year":"2014","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"12879","DOI":"10.1073\/pnas.0506001102","article-title":"Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome","volume":"102","author":"Capell","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nrg1906","article-title":"Human laminopathies: Nuclei gone genetically awry","volume":"7","author":"Capell","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/hmg\/ddi326","article-title":"Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition","volume":"14","author":"Glynn","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"12873","DOI":"10.1073\/pnas.0505767102","article-title":"Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes","volume":"102","author":"Toth","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"10291","DOI":"10.1073\/pnas.0504641102","article-title":"Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson\u2013Gilford progeria syndrome mutation","volume":"102","author":"Yang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"14416","DOI":"10.1073\/pnas.0503712102","article-title":"Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome","volume":"102","author":"Mallampalli","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1242\/jcs.03263","article-title":"DNA damage responses in progeroid syndromes arise from defective maturation of prelamin A","volume":"119","author":"Liu","year":"2006","journal-title":"J. Cell Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.5966\/sctm.2013-0168","article-title":"Induced pluripotent stem cells reveal functional differences between drugs currently investigated in patients with hutchinson-gilford progeria syndrome","volume":"3","author":"Blondel","year":"2014","journal-title":"Stem Cells Transl. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/j.yexcr.2010.05.015","article-title":"Defective DSB repair correlates with abnormal nuclear morphology and is improved with FTI treatment in Hutchinson-Gilford progeria syndrome fibroblasts","volume":"316","author":"Constantinescu","year":"2010","journal-title":"Exp. Cell Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s41021-015-0018-4","article-title":"Progerin, the protein responsible for the Hutchinson-Gilford progeria syndrome, increases the unrepaired DNA damages following exposure to ionizing radiation","volume":"37","author":"Noda","year":"2015","journal-title":"Genes Environ."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jprot.2013.08.008","article-title":"Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture","volume":"91","author":"Osorio","year":"2013","journal-title":"J. Proteom."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"64809","DOI":"10.18632\/oncotarget.19363","article-title":"Intermittent treatment with farnesyltransferase inhibitor and sulforaphane improves cellular homeostasis in Hutchinson-Gilford progeria fibroblasts","volume":"8","author":"Gabriel","year":"2017","journal-title":"Oncotarget"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10522-018-9758-4","article-title":"Farnesyltransferase inhibitor and rapamycin correct aberrant genome organisation and decrease DNA damage respectively, in Hutchinson-Gilford progeria syndrome fibroblasts","volume":"19","author":"Bikkul","year":"2018","journal-title":"Biogerontology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1073\/pnas.1019532108","article-title":"Protein farnesylation inhibitors cause donut-shaped cell nuclei attributable to a centrosome separation defect","volume":"108","author":"Verstraeten","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4161\/nucl.21675","article-title":"Blocking farnesylation of the prelamin A variant in Hutchinson-Gilford progeria syndrome alters the distribution of A-type lamins","volume":"3","author":"Wang","year":"2012","journal-title":"Nucleus"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1172\/JCI28968","article-title":"A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation","volume":"116","author":"Yang","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1172\/JCI35876","article-title":"Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated","volume":"118","author":"Yang","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1126\/science.1124875","article-title":"A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria","volume":"311","author":"Fong","year":"2006","journal-title":"Science"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"15902","DOI":"10.1073\/pnas.0807840105","article-title":"A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model","volume":"105","author":"Capell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"16666","DOI":"10.1073\/pnas.1202529109","article-title":"Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson\u2013Gilford progeria syndrome","volume":"109","author":"Gordon","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1001\/jama.2018.3264","article-title":"Association of Lonafarnib Treatment vs No Treatment with Mortality Rate in Patients with Hutchinson-Gilford Progeria Syndrome","volume":"319","author":"Gordon","year":"2018","journal-title":"JAMA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0021-9258(18)45960-1","article-title":"Isoprenylation of a protein kinase. Requirement of farnesylation\/alpha-carboxyl methylation for full enzymatic activity of rhodopsin kinase","volume":"267","author":"Inglese","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrm.2015.11","article-title":"Protein prenylation: Unique fats make their mark on biology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4161\/nucl.24089","article-title":"Disruption of lamin B1 and lamin B2 processing and localization by farnesyltransferase inhibitors","volume":"4","author":"Adam","year":"2013","journal-title":"Nucleus"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40265-020-01464-z","article-title":"Lonafarnib: First Approval","volume":"81","author":"Dhillon","year":"2021","journal-title":"Drugs"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3389\/fimmu.2018.00586","article-title":"Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines","volume":"9","author":"Rea","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4000","article-title":"Cellular senescence in aging and age-related disease: From mechanisms to therapy","volume":"21","author":"Childs","year":"2015","journal-title":"Nat. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1242\/jcs.00963","article-title":"The JAK\/STAT signaling pathway","volume":"117","author":"Rawlings","year":"2004","journal-title":"J. Cell Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.4049\/jimmunol.0902819","article-title":"Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: Preclinical characterization of INCB028050","volume":"184","author":"Fridman","year":"2010","journal-title":"J. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s40265-017-0856-4","article-title":"Baricitinib: A Review in Rheumatoid Arthritis","volume":"78","author":"Scott","year":"2018","journal-title":"Drugs"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e13122","DOI":"10.1111\/acel.13122","article-title":"The JAK1\/2 inhibitor ruxolitinib delays premature aging phenotypes","volume":"19","author":"Griveau","year":"2020","journal-title":"Aging Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3389\/fimmu.2018.01510","article-title":"Janus Kinase Inhibitor Baricitinib Modulates Human Innate and Adaptive Immune System","volume":"9","author":"Kubo","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrrheum.2017.23","article-title":"The emerging safety profile of JAK inhibitors in rheumatic disease","volume":"13","author":"Winthrop","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.8197455","article-title":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins","volume":"264","author":"Darnell","year":"1994","journal-title":"Science"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cytogfr.2014.10.011","article-title":"Type I IFN family members: Similarity, differences and interaction","volume":"26","author":"Capobianchi","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","article-title":"The senescence-associated secretory phenotype: The dark side of tumor suppression","volume":"5","author":"Desprez","year":"2010","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"89ra58","DOI":"10.1126\/scitranslmed.3002346","article-title":"Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells","volume":"3","author":"Cao","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"8963","DOI":"10.1073\/pnas.0402943101","article-title":"Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome","volume":"101","author":"Goldman","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"R\u00f6hrl, J.M., Arnold, R., and Djabali, K. (2021). Nuclear Pore Complexes Cluster in Dysmorphic Nuclei of Normal and Progeria Cells during Replicative Senescence. Cells, 10.","DOI":"10.3390\/cells10010153"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.cell.2012.01.059","article-title":"Accumulation of the inner nuclear envelope protein Sun1 is pathogenic in progeric and dystrophic laminopathies","volume":"149","author":"Chen","year":"2012","journal-title":"Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nm1266","article-title":"Genomic instability in laminopathy-based premature aging","volume":"11","author":"Liu","year":"2005","journal-title":"Nat. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"42462","DOI":"10.1074\/jbc.C100466200","article-title":"ATM phosphorylates histone H2AX in response to DNA double-strand breaks","volume":"276","author":"Burma","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/acel.12300","article-title":"Sulforaphane enhances progerin clearance in Hutchinson-Gilford progeria fibroblasts","volume":"14","author":"Gabriel","year":"2015","journal-title":"Aging Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/embr.201338126","article-title":"Antagonistic functions of LMNA isoforms in energy expenditure and lifespan","volume":"15","author":"Chavey","year":"2014","journal-title":"EMBO Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cmet.2015.11.011","article-title":"Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype","volume":"23","author":"Wiley","year":"2016","journal-title":"Cell Metab."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20110162","article-title":"Assessing mitochondrial dysfunction in cells","volume":"435","author":"Brand","year":"2011","journal-title":"Biochem. J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg Effect: How Does It Benefit Cancer Cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/BF01128816","article-title":"Increased glycolysis in ageing cultured human diploid fibroblasts","volume":"4","author":"Bittles","year":"1984","journal-title":"Biosci. Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1042\/bj20030816","article-title":"Metabolic analysis of senescent human fibroblasts reveals a role for AMP in cellular senescence","volume":"376","author":"Zwerschke","year":"2003","journal-title":"Biochem. J."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Gabriel, D., Gordon, L.B., and Djabali, K. (2016). Temsirolimus Partially Rescues the Hutchinson-Gilford Progeria Cellular Phenotype. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0168988"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1200\/JCO.2006.09.4243","article-title":"Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: A Pediatric Brain Tumor Consortium Study","volume":"25","author":"Kieran","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e12901","DOI":"10.1111\/acel.12901","article-title":"Extranuclear DNA accumulates in aged cells and contributes to senescence and inflammation","volume":"18","author":"Lan","year":"2019","journal-title":"Aging Cell"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"30451","DOI":"10.1074\/jbc.M003469200","article-title":"Farnesyl transferase inhibitors block the farnesylation of CENP-E and CENP-F and alter the association of CENP-E with the microtubules","volume":"275","author":"Ashar","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1083\/jcb.142.6.1547","article-title":"Active MAP kinase in mitosis: Localization at kinetochores and association with the motor protein CENP-E","volume":"142","author":"Zecevic","year":"1998","journal-title":"J. Cell Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1242\/jcs.115.17.3403","article-title":"Farnesylation of Cenp-F is required for G2\/M progression and degradation after mitosis","volume":"115","author":"Hussein","year":"2002","journal-title":"J. Cell Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature24050","article-title":"Cytoplasmic chromatin triggers inflammation in senescence and cancer","volume":"550","author":"Dou","year":"2017","journal-title":"Nature"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ncb3586","article-title":"Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence","volume":"19","author":"Guey","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1084\/jem.20180139","article-title":"The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer","volume":"215","author":"Li","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nature08476","article-title":"STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity","volume":"461","author":"Ishikawa","year":"2009","journal-title":"Nature"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1101\/gad.197954.112","article-title":"Nuclear lamina defects cause ATM-dependent NF-\u03baB activation and link accelerated aging to a systemic inflammatory response","volume":"26","author":"Osorio","year":"2012","journal-title":"Genes Dev."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Bidault, G., Garcia, M., Capeau, J., Morichon, R., Vigouroux, C., and B\u00e9r\u00e9ziat, V. (2020). Progerin Expression Induces Inflammation, Oxidative Stress and Senescence in Human Coronary Endothelial Cells. Cells, 9.","DOI":"10.3390\/cells9051201"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev-physiol-030212-183653","article-title":"Aging, cellular senescence, and cancer","volume":"75","author":"Campisi","year":"2013","journal-title":"Annu. Rev. Physiol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Copp\u00e9, J.-P., Patil, C.K., Rodier, F., Sun, Y., Mu\u00f1oz, D.P., Goldstein, J., Nelson, P.S., Desprez, P.-Y., and Campisi, J. (2008). Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol., 6.","DOI":"10.1371\/journal.pbio.0060301"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/gerona\/glu057","article-title":"Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases","volume":"69","author":"Franceschi","year":"2014","journal-title":"J. Gerontol. Ser. A Biol. Sci. Med. Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41568-019-0156-2","article-title":"Unmasking senescence: Context-dependent effects of SASP in cancer","volume":"19","author":"Faget","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.leu.2402832","article-title":"The farnesyl transferase inhibitor, FTI-277, inhibits growth and induces apoptosis in drug-resistant myeloma tumor cells","volume":"17","author":"Bolick","year":"2003","journal-title":"Leukemia"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1124\/mol.63.1.159","article-title":"Growth inhibition by the farnesyltransferase inhibitor FTI-277 involves Bcl-2 expression and defective association with Raf-1 in liver cancer cell lines","volume":"63","author":"Mazzocca","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11357-018-0030-2","article-title":"Rapamycin increases oxidative metabolism and enhances metabolic flexibility in human cardiac fibroblasts","volume":"40","author":"Nacarelli","year":"2018","journal-title":"Geroscience"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3389\/fphys.2019.01523","article-title":"Where Metabolism Meets Senescence: Focus on Endothelial Cells","volume":"10","author":"Sabbatinelli","year":"2019","journal-title":"Front. Physiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"29215","DOI":"10.1074\/jbc.M113.482570","article-title":"The ATP costs and time required to degrade ubiquitinated proteins by the 26 S proteasome","volume":"288","author":"Peth","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/ATVBAHA.118.311444","article-title":"Synthesis of Extracellular Pyrophosphate Increases in Vascular Smooth Muscle Cells during Phosphate-Induced Calcification","volume":"38","year":"2018","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"23698","DOI":"10.1073\/pnas.1910972116","article-title":"ATP-based therapy prevents vascular calcification and extends longevity in a mouse model of Hutchinson-Gilford progeria syndrome","volume":"116","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/ki.2013.521","article-title":"Vascular calcification is dependent on plasma levels of pyrophosphate","volume":"85","author":"Lomashvili","year":"2014","journal-title":"Kidney Int."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature13193","article-title":"The role of senescent cells in ageing","volume":"509","year":"2014","journal-title":"Nature"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1172\/JCI95148","article-title":"Mechanisms and functions of cellular senescence","volume":"128","author":"Herranz","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ebiom.2015.02.015","article-title":"Reversal of Alopecia Areata Following Treatment with the JAK1\/2 Inhibitor Baricitinib","volume":"2","author":"Jabbari","year":"2015","journal-title":"EBioMedicine"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","article-title":"A biomarker that identifies senescent human cells in culture and in aging skin in vivo","volume":"92","author":"Dimri","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Ye, J., Coulouris, G., Zaretskaya, I., Cutcutache, I., Rozen, S., and Madden, T.L. (2012). Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction. BMC Bioinform., 13.","DOI":"10.1186\/1471-2105-13-134"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/14\/7474\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:29:30Z","timestamp":1760164170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/14\/7474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,12]]},"references-count":92,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["ijms22147474"],"URL":"https:\/\/doi.org\/10.3390\/ijms22147474","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,12]]}}}